Completed PHASE4 INTERVENTIONAL 2-arm NCT00521027

Study Comparing VERSAJET With Conventional Surgical Procedures in the Removal of Unhealthy Tissue From Lower Limb Ulcers

A Prospective, Comparative, Single-centre Clinical Evaluation to Investigate the Skin-to-skin Time of the First Surgical Debridement of Lower Extremity Ulcers With VERSAJET™ Hydrosurgery System and Conventional Debridement Techniques.

Sponsor: Smith & Nephew, Inc.

Conditions Diabetic Foot Pressure Ulcer Varicose Ulcer

Interventions Conventional surgical debridement techniques Versajet Hydrosurgery System

Updated 6 times since 2017 Last updated: Feb 14, 2018 Started: Apr 30, 2006 Completion: Sep 30, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00521027, this PHASE4 trial focuses on Diabetic Foot and Pressure Ulcer and remains completed. Sponsored by Smith & Nephew, Inc., it has been updated 6 times since 2006, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Mar 2018 — Jun 2018 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Mar 2018 [monthly]

Completed PHASE4

First recorded

Apr 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Smith & Nephew, Inc.

Data source: Smith & Nephew, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Belleville, United States